Fidelity Investments
ANIX icon

Fidelity Investments’s Anixa Biosciences ANIX Stock Holding History

Fidelity Investments’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-250
Closed -$780 – 5353
2024
Q1 		$780 Buy
+250
New +$997 ﹤0.01% 4804

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Fidelity Investments's ANIX Position: Q2 2024 in Review

Fidelity Investments sold out of Anixa Biosciences (ANIX) in Q2 2024, closing a stake of 250 shares — an estimated $780 sold.

Fidelity Investments first reported a position in ANIX in Q1 2024 and held it in 1 quarter. The position peaked at $780 in Q1 2024. 53 funds tracked by Wall St. Rank hold ANIX as of Q2 2024.

  • Fidelity Investments reported no remaining Anixa Biosciences position as of Q2 2024 after selling out during the quarter.
  • Fidelity Investments sold 250 Anixa Biosciences shares in Q2 2024, an estimated $780.
  • Fidelity Investments first reported a position in Anixa Biosciences in Q1 2024 and held it in 1 quarter.
  • Fidelity Investments's Anixa Biosciences position peaked at $780 in Q1 2024.
  • 53 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.